Computational Life is a United States-based startup founded in 2018 with a focus on Health Care and Medical Devices. The company's flagship product, Altegos™, is the first patient-specific, predictive decision support software for shock care.
Altegos™ functions as a cardiopulmonary digital twin for shock patients, utilizing mathematical deterministic models of human physiology validated against bench tests and real clinical measurements. This approach sets it apart from traditional AI software, enabling it to reconstruct physical processes underlying specific scenarios without reliance on extensive previous data.
Altegos™' capabilities extend to simulating and predicting patient-specific outcomes of treatments and pathological conditions, including cases with no prior experience. This unique approach reduces errors, increases survival rates, decreases readmission rates, and shortens the length of stay for patients affected by shock.
The company secured a $300.00K Convertible Note investment on 01 April 2023. The investor information is currently unavailable. Computational Life's innovation in predictive decision support software positions it at the forefront of revolutionizing shock care in the healthcare industry.